Publications 2024

Kirkeby K, Cockerell I, Christensen J, Hoei-Hansen CE, Holst L, Fredriksen MG, Lund C, Johannessen Landmark C (2024)
Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway
Medicine (Baltimore), 103 (32), e39244
DOI 10.1097/MD.0000000000039244, PubMed 39121325

Publications 2023

Cockerell I, Christensen J, Hoei-Hansen CE, Holst L, Grenaa Frederiksen M, Issa-Epe AI, Nedregaard B, Solhoff R, Heimdal K, Johannessen Landmark C, Lund C, Nærland T (2023)
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
Orphanet J Rare Dis, 18 (1), 377
DOI 10.1186/s13023-023-02982-1, PubMed 38042867

Villagrán A, Lund C, Duncan R, Ingvar Lossius M (2023)
Adverse life events in patients with functional seizures: Assessment in clinical practice and association with long-term outcome
Epilepsy Behav, 148, 109456
DOI 10.1016/j.yebeh.2023.109456, PubMed 37804600

Publications 2022

Johannesen KM, Liu Y, Koko M, Gjerulfsen CE, Sonnenberg L, Schubert J, Fenger CD, Eltokhi A, Rannap M, Koch NA, Lauxmann S, Krüger J, Kegele J, Canafoglia L, Franceschetti S, Mayer T, Rebstock J, Zacher P, Ruf S, Alber M, Sterbova K, Lassuthová P, Vlckova M, Lemke JR, Platzer K et al. (2022)
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications
Brain, 145 (9), 2991-3009
DOI 10.1093/brain/awab321, PubMed 34431999

Villagrán A, Lund C, Duncan R, Lossius MI (2022)
The effect of attachment style on long-term outcomes in psychogenic nonepileptic seizures: Results from a prospective study
Epilepsy Behav, 135, 108890
DOI 10.1016/j.yebeh.2022.108890, PubMed 36037581

Publications 2020

Heger K, Lund C, Larsen Burns M, Bjørnvold M, Sætre E, Johannessen SI, Johannessen Landmark C (2020)
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
Epilepsia Open, 5 (3), 432-441
DOI 10.1002/epi4.12413, PubMed 32913951

Johannessen Landmark C, Heger K, Lund C, Burns ML, Bjørnvold M, Sætre E, Johannessen SI (2020)
Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome
Ther Drug Monit, 42 (5), 744-753
DOI 10.1097/FTD.0000000000000781, PubMed 32558674

Publications 2017

Tuft M, Østby Y, Nakken KO, Lund C (2017)
Aicardi syndrome and cognitive abilities: A report of five cases
Epilepsy Behav, 73, 161-165
DOI 10.1016/j.yebeh.2017.05.002, PubMed 28641168

Publications 2016

Lund C, Striano P, Sorte HS, Parisi P, Iacomino M, Sheng Y, Vigeland MD, Øye AM, Møller RS, Selmer KK, Zara F (2016)
Exome Sequencing Fails to Identify the Genetic Cause of Aicardi Syndrome
Mol Syndromol, 7 (4), 234-238
DOI 10.1159/000448367, PubMed 27781033

Publications 2014

Lund C, Bjørnvold M, Tuft M, Kostov H, Røsby O, Selmer KK (2014)
Aicardi syndrome: an epidemiologic and clinical study in Norway
Pediatr Neurol, 52 (2), 182-6.e3
DOI 10.1016/j.pediatrneurol.2014.10.022, PubMed 25443581

Lund C, Brodtkorb E, Øye AM, Røsby O, Selmer KK (2014)
CHD2 mutations in Lennox-Gastaut syndrome
Epilepsy Behav, 33, 18-21
DOI 10.1016/j.yebeh.2014.02.005, PubMed 24614520

Publications 2013

Lund C, Brodtkorb E, Røsby O, Rødningen OK, Selmer KK (2013)
Copy number variants in adult patients with Lennox-Gastaut syndrome features
Epilepsy Res, 105 (1-2), 110-7
DOI 10.1016/j.eplepsyres.2013.01.009, PubMed 23415449

Lund C, Karterud HN (2013)
Seizures that are not epileptic
Tidsskr Nor Laegeforen, 133 (5), 537
DOI 10.4045/tidsskr.13.0010, PubMed 23463068

Publications 2012

Lund C, Bremer A, Lossius MI, Selmer KK, Brodtkorb E, Nakken KO (2012)
[Dravet syndrome as a cause of epilepsy and learning disability]
Tidsskr Nor Laegeforen, 132 (1), 44-7
DOI 10.4045/tidsskr.11.0539, PubMed 22240828

Publications 2011

Lund C, Brodtkorb E, Nakken KO (2011)
[Lennox-Gastaut syndrome--course and treatment]
Tidsskr Nor Laegeforen, 131 (1), 24-7
DOI 10.4045/tidsskr.09.1540, PubMed 21233883

Publications 2010

Lund C, Kostov H, Blomskjøld B, Nakken KO (2010)
Efficacy and tolerability of long-term treatment with vagus nerve stimulation in adolescents and adults with refractory epilepsy and learning disabilities
Seizure, 20 (1), 34-7
DOI 10.1016/j.seizure.2010.10.002, PubMed 21035358

Publications 2009

Lund C, Haraldsen I, Lossius MI, Bjørnaes H, Lossius R, Nakken KO (2009)
[Psychogenic non-epileptic seizures]
Tidsskr Nor Laegeforen, 129 (22), 2348-51
DOI 10.4045/tidsskr.09.0300, PubMed 19935934

Selmer KK, Lund C, Brandal K, Undlien DE, Brodtkorb E (2009)
SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features
Epilepsy Behav, 16 (3), 555-7
DOI 10.1016/j.yebeh.2009.08.021, PubMed 19782004